BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu H, Tian X, Zhu C. Knockdown of lncRNA PVT1 inhibits prostate cancer progression in vitro and in vivo by the suppression of KIF23 through stimulating miR-15a-5p. Cancer Cell Int 2020;20:283. [PMID: 32624708 DOI: 10.1186/s12935-020-01363-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Tortora F, La Civita E, Trivedi P, Febbraio F, Terracciano D, Cimmino A. Emerging RNA-Based Therapeutic and Diagnostic Options: Recent Advances and Future Challenges in Genitourinary Cancers. Int J Mol Sci 2023;24. [PMID: 36902032 DOI: 10.3390/ijms24054601] [Reference Citation Analysis]
2 Al-Shehri A, Bakhashab S. Oncogenic Long Noncoding RNAs in Prostate Cancer, Osteosarcoma, and Metastasis. Biomedicines 2023;11. [PMID: 36831169 DOI: 10.3390/biomedicines11020633] [Reference Citation Analysis]
3 Hashemi M, Hajimazdarany S, Mohan CD, Mohammadi M, Rezaei S, Olyaee Y, Goldoost Y, Ghorbani A, Mirmazloomi SR, Gholinia N, Kakavand A, Salimimoghadam S, Ertas YN, Rangappa KS, Taheriazam A, Entezari M. Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106535] [Reference Citation Analysis]
4 Li R, Wang X, Zhu C, Wang K. lncRNA PVT1: a novel oncogene in multiple cancers. Cell Mol Biol Lett 2022;27:84. [PMID: 36195846 DOI: 10.1186/s11658-022-00385-x] [Reference Citation Analysis]
5 Mirzaei S, Paskeh MDA, Okina E, Gholami MH, Hushmandi K, Hashemi M, Kalu A, Zarrabi A, Nabavi N, Rabiee N, Sharifi E, Karimi-Maleh H, Ashrafizadeh M, Kumar AP, Wang Y. Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention. J Exp Clin Cancer Res 2022;41:214. [PMID: 35773731 DOI: 10.1186/s13046-022-02406-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
6 Gong Y, Zhou L, Ding L, Zhao J, Wang Z, Ren G, Zhang J, Mao Z, Zhou R. KIF23 is a potential biomarker of diffuse large B cell lymphoma: Analysis based on bioinformatics and immunohistochemistry. Medicine (Baltimore) 2022;101:e29312. [PMID: 35713434 DOI: 10.1097/MD.0000000000029312] [Reference Citation Analysis]
7 Huang H, Zhong P, Zhang J, Chen X, Chen J, Lin T, Wu Q. Human umbilical cord-mesenchymal stem cells-derived exosomes carrying microRNA-15a-5p possess therapeutic effects on Wilms tumor via regulating septin 2. Bioengineered 2022;13:6136-49. [PMID: 35200105 DOI: 10.1080/21655979.2022.2037379] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Chen Q, Yang X, Gong B, Xie W, Ma M, Fu S, Wang S, Liu Y, Zhang Z, Sun T, Li Z. SNHG10 Is a Prognostic Biomarker Correlated With Immune Infiltrates in Prostate Cancer. Front Cell Dev Biol 2021;9:731042. [PMID: 34676212 DOI: 10.3389/fcell.2021.731042] [Reference Citation Analysis]
9 Zhao Y, Yuan D, Zhu D, Xu T, Huang A, Jiang L, Liu C, Qian H, Bu X. LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p. J Ovarian Res 2021;14:109. [PMID: 34454554 DOI: 10.1186/s13048-021-00857-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Jian W, Deng XC, Munankarmy A, Borkhuu O, Ji CL, Wang XH, Zheng WF, Yu YH, Zhou XQ, Fang L. KIF23 promotes triple negative breast cancer through activating epithelial-mesenchymal transition. Gland Surg 2021;10:1941-50. [PMID: 34268078 DOI: 10.21037/gs-21-19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
11 Wang LP, Lin J, Ma XQ, Xu DY, Shi CF, Wang W, Jiang XJ. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis. J Exp Clin Cancer Res 2021;40:177. [PMID: 34039401 DOI: 10.1186/s13046-021-01973-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
12 Hao W, Zhao H, Li Z, Li J, Guo J, Chen Q, Gao Y, Ren M, Zhao X, Yue W. Identification of potential markers for differentiating epithelial ovarian cancer from ovarian low malignant potential tumors through integrated bioinformatics analysis. J Ovarian Res 2021;14:46. [PMID: 33726773 DOI: 10.1186/s13048-021-00794-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Liu HW, Hu ZL, Li H, Tan QF, Tong J, Zhang YQ. Knockdown of lncRNA ANRIL suppresses the production of inflammatory cytokines and mucin 5AC in nasal epithelial cells via the miR-15a-5p/JAK2 axis. Mol Med Rep 2021;23:145. [PMID: 33325534 DOI: 10.3892/mmr.2020.11784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Xia H, Zhang Z, Yuan J, Niu Q. The lncRNA PVT1 promotes invasive growth of lung adenocarcinoma cells by targeting miR-378c to regulate SLC2A1 expression. Hum Cell 2021;34:201-10. [PMID: 32960438 DOI: 10.1007/s13577-020-00434-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]